Childhood arterial ischemic stroke: A review of etiologies, antithrombotic treatments, prognostic factors, and priorities for future research

Courtney A. Lyle, Timothy J. Bernard, Neil Goldenberg

Research output: Contribution to journalArticle

Abstract

Childhood arterial ischemic stroke (AIS) is a rare, but serious, medical condition, which is fatal in approximately 3% and associated with both acute and long-term neurologic impairment in over 70% of cases. Common etiologies include sickle cell disease, congenital heart disease, arterial dissection, prothrombotic conditions, and preceding viral infections; however, one in four cases is considered idiopathic. To date, no randomized controlled clinical trials (RCTs) have been conducted to establish evidence for current therapeutic strategies outside of sickle cell disease, thus, treatment strategies are largely shaped by consensus-based guidelines, in which, beyond the acute period, aspirin is the mainstay of therapy and anticoagulation is reserved for select circumstances. In recent years, evidence on prognostic factors has accumulated, helping to inform the future design of prognostically stratified RCTs. In this narrative review, we discuss the current understanding of etiologies, consensus-based treatment recommendations, contemporary treatment data, and prognostic factors in childhood AIS. We also identify priorities for future research.

Original languageEnglish (US)
Pages (from-to)786-793
Number of pages8
JournalSeminars in Thrombosis and Hemostasis
Volume37
Issue number7
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Sickle Cell Anemia
Randomized Controlled Trials
Stroke
Virus Diseases
Nervous System
Aspirin
Dissection
Heart Diseases
Guidelines
Therapeutics

Keywords

  • Childhood arterial ischemic stroke
  • pediatric stroke

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

Childhood arterial ischemic stroke : A review of etiologies, antithrombotic treatments, prognostic factors, and priorities for future research. / Lyle, Courtney A.; Bernard, Timothy J.; Goldenberg, Neil.

In: Seminars in Thrombosis and Hemostasis, Vol. 37, No. 7, 2011, p. 786-793.

Research output: Contribution to journalArticle

@article{667fac2b75304c81ba641d036eb7a88f,
title = "Childhood arterial ischemic stroke: A review of etiologies, antithrombotic treatments, prognostic factors, and priorities for future research",
abstract = "Childhood arterial ischemic stroke (AIS) is a rare, but serious, medical condition, which is fatal in approximately 3{\%} and associated with both acute and long-term neurologic impairment in over 70{\%} of cases. Common etiologies include sickle cell disease, congenital heart disease, arterial dissection, prothrombotic conditions, and preceding viral infections; however, one in four cases is considered idiopathic. To date, no randomized controlled clinical trials (RCTs) have been conducted to establish evidence for current therapeutic strategies outside of sickle cell disease, thus, treatment strategies are largely shaped by consensus-based guidelines, in which, beyond the acute period, aspirin is the mainstay of therapy and anticoagulation is reserved for select circumstances. In recent years, evidence on prognostic factors has accumulated, helping to inform the future design of prognostically stratified RCTs. In this narrative review, we discuss the current understanding of etiologies, consensus-based treatment recommendations, contemporary treatment data, and prognostic factors in childhood AIS. We also identify priorities for future research.",
keywords = "Childhood arterial ischemic stroke, pediatric stroke",
author = "Lyle, {Courtney A.} and Bernard, {Timothy J.} and Neil Goldenberg",
year = "2011",
doi = "10.1055/s-0031-1297169",
language = "English (US)",
volume = "37",
pages = "786--793",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "7",

}

TY - JOUR

T1 - Childhood arterial ischemic stroke

T2 - A review of etiologies, antithrombotic treatments, prognostic factors, and priorities for future research

AU - Lyle, Courtney A.

AU - Bernard, Timothy J.

AU - Goldenberg, Neil

PY - 2011

Y1 - 2011

N2 - Childhood arterial ischemic stroke (AIS) is a rare, but serious, medical condition, which is fatal in approximately 3% and associated with both acute and long-term neurologic impairment in over 70% of cases. Common etiologies include sickle cell disease, congenital heart disease, arterial dissection, prothrombotic conditions, and preceding viral infections; however, one in four cases is considered idiopathic. To date, no randomized controlled clinical trials (RCTs) have been conducted to establish evidence for current therapeutic strategies outside of sickle cell disease, thus, treatment strategies are largely shaped by consensus-based guidelines, in which, beyond the acute period, aspirin is the mainstay of therapy and anticoagulation is reserved for select circumstances. In recent years, evidence on prognostic factors has accumulated, helping to inform the future design of prognostically stratified RCTs. In this narrative review, we discuss the current understanding of etiologies, consensus-based treatment recommendations, contemporary treatment data, and prognostic factors in childhood AIS. We also identify priorities for future research.

AB - Childhood arterial ischemic stroke (AIS) is a rare, but serious, medical condition, which is fatal in approximately 3% and associated with both acute and long-term neurologic impairment in over 70% of cases. Common etiologies include sickle cell disease, congenital heart disease, arterial dissection, prothrombotic conditions, and preceding viral infections; however, one in four cases is considered idiopathic. To date, no randomized controlled clinical trials (RCTs) have been conducted to establish evidence for current therapeutic strategies outside of sickle cell disease, thus, treatment strategies are largely shaped by consensus-based guidelines, in which, beyond the acute period, aspirin is the mainstay of therapy and anticoagulation is reserved for select circumstances. In recent years, evidence on prognostic factors has accumulated, helping to inform the future design of prognostically stratified RCTs. In this narrative review, we discuss the current understanding of etiologies, consensus-based treatment recommendations, contemporary treatment data, and prognostic factors in childhood AIS. We also identify priorities for future research.

KW - Childhood arterial ischemic stroke

KW - pediatric stroke

UR - http://www.scopus.com/inward/record.url?scp=84055222141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84055222141&partnerID=8YFLogxK

U2 - 10.1055/s-0031-1297169

DO - 10.1055/s-0031-1297169

M3 - Article

C2 - 22187401

AN - SCOPUS:84055222141

VL - 37

SP - 786

EP - 793

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 7

ER -